This Blog Is Powered By Life Technology™. Visit Life Technology™ At www.lifetechnology.com Subscribe To This Blog Via Feedburner / Atom 1.0 / RSS 2.0.
Thursday, 15 September 2022
The staggering costs of COVID-19: 11 ways to stop history from repeating itself
A global report released today highlights massive global failures in the response to COVID-19.
Vaccine that targets both spike and nucleocapsid proteins in SARS-CoV-2 virus found effective in test animals
A large team of researchers at the University of Texas Medical Branch, working with two colleagues from the University of Pennsylvania Perelman School of Medicine and two with the Mayo Clinic, has developed a vaccine for COVID-19 that targets both the spike and nucleocapsid proteins in the SARS-CoV-2 virus. In their paper published in the journal Science Translational Medicine, the group explains their approach to developing the new vaccine and describes how well it worked in test mice and hamsters.
Imagining COVID is 'like the flu' is cutting thousands of lives short. It's time to wake up
It is difficult to understand the ease with which we have accepted a major proportion of the Australian population getting infected with COVID in just a matter of months. Many have been infected multiple times, potentially exposing them to long COVID and other problems we are only beginning to understand. In the past 75 years, only the second world war has had a greater demographic impact on Australia than COVID in 2022.
Nutritionally balanced and whole-food-based, fiber-rich diet is beneficial to gut health
The gut microbiome, or gut microbiota, also termed commensal, refers to the entire microbial community that populates the mammalian gastrointestinal tract, with the majority residing in the colon. Through generating a diverse array of metabolites, the gut microbiome interacts with the gut epithelium and the intestinal mucosal immune system to maintain gut homeostasis, thus forming a symbiotic relationship with the host.
New tool guides clinicians to identify and treat patients at risk for monkeypox virus
Monkeypox was rarely seen outside West and Central Africa until the current 2022 global outbreak, and clinicians are now on alert to identify, isolate, and treat individuals infected with the virus that causes it. A team led by investigators at Massachusetts General Hospital (MGH) recently developed and implemented a clinical decision support system to help with this effort.
Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy
A single research test has the potential to predict which patients treated with immunotherapies—which harness the immune system to attack cancer cells—are likely to have their cancer recur or have severe side effects, a new study found.
Bangladeshi mystic fights demons with psychiatry
Evil spirits bedevil the families that seek blessings from an elderly Bangladeshi mystic—but he knows his prayers alone are not enough to soothe their troubled minds.
Subscribe to:
Posts (Atom)